The Relationship Between Peripheral Eosinophilia, Lower Respiratory Tract Pathogens, Age at First Pneumonia, and Malnutrition in Children with Non-cystic Fibrosis Bronchiectasis. [PDF]
Olgun EG +9 more
europepmc +1 more source
Bringing together experts in reflux diseases, including gastroenterologists, surgeons, endoscopists, laryngologists, pulmonologists, and research scientists, the inaugural Gatherings in Esophagology (GiE) was held May 30–31, 2025, in France as a new initiative of Organisation mondiale d'Etudes Spécialisées pour les maladies de l'Oesophage (OESO).
Jennifer Cable +38 more
wiley +1 more source
LILRB1 Modulates Neutrophil Migration, NETosis, and Inflammation in Drug-Resistant <i>Pseudomonas aeruginosa</i>-Associated Bronchiectasis. [PDF]
Zheng S +11 more
europepmc +1 more source
Associations between respiratory signs and abnormalities reported in thoracic CT scans of cats [PDF]
Aarsvold +28 more
core +2 more sources
Therapies for bronchiectasis: mechanisms and potential effects. [PDF]
Yu L, Zhu HR, Jin XH, Ding J, Jin T.
europepmc +1 more source
Allergy occurred in 27% of 60 CVID patients, while IgE deficiency was observed in 65% and was strongly correlated with serum IgA levels. Low serum IgE/IgA levels accurately identified lymphoproliferative and granulomatous phenotypes, thereby improving diagnostic and prognostic stratification in CVID.
Maria Giovanna Danieli +9 more
wiley +1 more source
Clinical Characteristics and Risk Factors Analysis of Nontuberculous Mycobacterial Pulmonary Disease Complicated with Bronchiectasis. [PDF]
Li J, Zeng P, Mu X, Cai C.
europepmc +1 more source
E‐cigarette exposure impairs skeletal muscle mitochondrial function in male mice
E‐cigarette vapor induces skeletal muscle mitochondrial dysfunction through AHR‐independent pathways. Abstract While conventional tobacco‐cigarette smoking continues to decline, e‐cigarette (E‐cig) use is rising, yet its physiological consequences remain poorly characterized.
Pavel Mazirka +9 more
wiley +1 more source
Design and rationale of the AIR-NET trial: a randomised, open-label, multifactorial, multicentre, adaptive platform trial using a range of repurposed anti-inflammatory treatments to improve outcomes in patients with bronchiectasis within the EMBARC clinical research network. [PDF]
Long MB +20 more
europepmc +1 more source

